ALFA Finder| Management target | Revenue 2028 |
|---|
| Margins | Focus on cost-effective sustainable solutions to maintain margins. |
|---|---|
| Order book | Sizable orders from leading oil and gas companies. |
| Demand visibility | Strong in US oilfield chemicals and sustainable textile solutions. |
| Management confidence | High regarding US market penetration and sustainability-led growth. |
Growth
Revenue mix is 77% international and 23% domestic. Total manufacturing capacity reached 268,000 MTPA following US expansion.
Outlook
Targeting $200M+ revenue from US specialty oil and gas chemicals by 2028; projected North America market size of $19.8B by 2035.
Risks
Exposure to volatile oil and gas sector demand and international regulatory compliance (REACH, GOTS).
Investor Presentation filed with BSE, NSE: FCL. Summary written with AI assistance from the document.
Fineotex Chemical Ltd: key numbers
- Share price
- ₹51.50
- Market cap
- ₹5,997 Cr
- Revenue (annual)
- ₹772.2 Cr
- Net profit (annual)
- ₹108.8 Cr
- P/E (TTM)
- 49.0×Sector 35.5×
- Promoter holding
- 62.30%+0.00% QoQ
- FII holding
- 2.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fineotex Chemical Ltd
All →Fineotex Chemical Board Meeting Date
Fineotex Chemical Ltd has scheduled a board meeting on November 13, 2026. The board will consider unaudited financial results for the quarter and half-year ended September 30, 2026.
Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new US-based subsidiary, Fineotex America Inc., for ₹0.05 Crore to provide specialized water treatment solutions.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical's FZE subsidiary incorporated Fineotex America Inc. in Delaware, USA. The entity will supply water treatment chemicals for data centers and semiconductors.
Fineotex Chemical Annual General Meeting
Fineotex Chemical Limited conducted its 23rd Annual General Meeting on September 11, 2026. Shareholders discussed ordinary and special business items, including dividend and fund raising proposals.
Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new wholly-owned subsidiary, Fineotex Holdings Inc., in the USA for specialty chemical business activities.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical Limited incorporated a new wholly-owned step-down subsidiary, Fineotex Holdings Inc., in the USA. This entity will pursue specialty chemical and growth opportunities.